Irish bio-tech company Elan looks set to be sold, with management sensationally announcing yesterday that it has authorised a formal sale process to commence.

DEALMAKERS could find themselves with even more free time on their hands next year if Europe’s fiscal roadmap fails to convince investors and stabilise global markets.